Immune reconstitution after autologous progenitor hemopoietic cells transplantation. a study comparing autologous bone marrow and autologous peripheral blood transplantation;Recuperación inmune tras trasplante autólogo de células progenitoras hemopoyéticas. Comparación entre células progenitoras de sangre periférica y de médula ósea

Medicina Clinica

Volumn 110, Issue 20, 1998, Pages 768-773

  Hernández, Ma Dolores ^a   Del Cañizo, Ma Consuelo ^a   González, Marcos ^a   Caballero, Ma Dolores ^a   López Berges, Ma Consuelo ^a   Vázquez, Lourdes ^a   Orfao, Alberto ^a   Corral, Mercedes ^a   Nieto, Ma Jesús ^a   San Miguel, Jesús F ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; AUTOTRANSPLANTATION; B LYMPHOCYTE; BLOOD DISEASE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; COMPARATIVE STUDY; CYTOTOXICITY TEST; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; MIDDLE AGED; NATURAL KILLER CELL; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; ANTIGENS, CD19; ANTIGENS, CD3; B-LYMPHOCYTE SUBSETS; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY TESTS, IMMUNOLOGIC; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0032490207     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Langenmaye I, Weaver C, Buckner CD, Lilleby K, Appelbaum FR, Longin K et al. Engrfatment of patients with lymphoid malignancies trasplanted with autologous bone marrow, peripheral blood stem cells or both. Bone Marrow Transplant 1995; 15: 241-246.
2. San Miguel JF, Hernández MD, González M, López-Berges MC, Caballero MD, Vázquez L et al. A randomized study comparing the effect of GM-CSF and G-CSF on immune reconstitution after autologous bone marrow transplantation. Br J Haematol 1996; 94: 140-147.
3. San Miguel JF, González M, Gascón A, Moro MJ, Hernández JF, Ortega F et al. Immunophenotype heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Br J Haematol 1991; 77: 185-190.
4. Macedo A, Orfao A, Ciudad J, González M, Vidriales B, López-Berges MC et al. Phenotypic analysis of CD34 subpopulations in normal human bone marrow. Its applications for the detection of minimal residual disease. Leukemia 1995; 9: 1.896-1.901.
5. Snedecor GW, Cachran WG. Statistical methods (7. a ed.). Ames Iowa: Iowa State University Press, 1987; 143-147.
6. Lum LG, Ueda M. Immunodeficiency and the role of supressor cells after human bone marrow transplantation. Clin Immunol Immunopathol 1992; 63: 103-109.
7. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987; 69: 369-380.
8. Roberts MM, To LB, Gillis D, Mundy J, Rawwling C, Ng K et al. Immune reconstitution following peripheral blood stem cell transplantation, autologons bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12: 469-475.
9. Ashihara E, Shimazaki C, Yamagata N, Hirata T, Okawa K, Oku N et al. Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis. Bone Marrow Transplant 1994; 13: 377-381.
10. Foot ABM, Potter MN, Donaldson C. Cornish JM, Wallington TB, Oakhill A et al. Immune reconstitution after BMT in children. Bone Marrow Transplant 1993; 11: 7-13.
11. Takaue Y, Okamoto Y, Kawano Y, Suzue T, Abe T, Saito SI et al. Regeneration of immunity and varicella-zoster virus infection after high-dose chemotherapy and peripheral blood stem cell autografts in children. Bone Marrow Transplant 1994; 14: 219-223.
12. Kessinger A, Armitage JO, Smith M, Landmark D, Bierman PJ, Weisenburger DD. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 1989; 74: 1.260-1.265.
13. Rabian-Herzog C, Lesage S, Gluckman E. Characterization of lymphocyte populations in cord blood. Bone Marrow Transplant 1992; 9: 64-67.
14. Ichikawa Y, Shimizu H, Yoshida M, Takaya M, Arimori S. Accessory molecules expresed on the peripheral blood or synovial fluid T lymphocytes form patients with Sjögren's syndrome or rheumatoid arthritis Clin Exp Rheumatol 1992; 10: 447-454.
15. Fox E, Lewis D, Deemer K, El Masry M, Rich R. T suppressor cell growth factor and anti-CD3 antibodies stimule reciprocal subsets of T lymphocytes. J Exp Med 1987; 166: 404-418.
16. Aotsuka N, Asai T, Oh H, Yoshida S, Itoh K, Sato T. Lymphocyte subset reconstitution following human allogeneic bone marrow transplantation: differences between engrafted patients and graft failure patients. Bone Marrow Transplant 1991; 8: 345-349.
17. Mackall CL, Granger L, Sheard MA, Cepeda R, Gress RE. T-cell regeneration after bone marrow transplantation: differential CD45 Isoform expression on thymic-derived versus thymic-independent progeny. Blood 1993; 82: 2.585-2.594.
18. Leino L, Lilius EM, Nikoskelainen J, Pelliniemi TT, Rajamäki A. The reappearance of 10 differentiation antigens on peripheral blood lymphocytes after allogenic bone marrow transplantation Bone Marrow Transplant 1991; 8: 339-344.
19. Michie CA, McLean AR. Bone marrow transplantation and lymphocyte subset kinetics. Bone Marrow Transplant 1993; 12: 547.
20. Summers KL, O'Donnell JL, Hart DNJ. Co-expression of the CD45RA and CD45RO antigens on T lymphocytes in chronic arthritis. Clin Exp Immunol 1994; 97: 39-44.
21. Imboden JB. The regulation of intracellular signals during B lymphocyte activation, Immunol Today 1988, 9: 17-18.
22. Gordon J, Guy GR. En: Bird G, Calvert JE, editores. B lymphocytes in human disease. Oxford: Oxford University Press, 1988; 148-173.
23. Small TN, Keever CA, Weiner-Fedus S, Heller G, O'Reilly RJ, Flcmenberg N. B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood 1990; 76: 1.647-1.656.
24. Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 1993; 12: 387-398.
25. Antin JH, Ault KA, Rappeport JM, Smith BR. B lymphocyte reconstitution after bone marrow transplantation: Leu-1 antigens defines a distinct population of B lymphocytes. J Clin Invest 1987; 80: 325-332.
26. Drexler HG, Brenner MWK, Wimperis JZ, Gignac SM, Janossy G, Prentice et al. CD-5 positive B cells after T cell depleted bone marrow transplantation. Clin Exp Immunol 1987; 68: 662-668.
27. Reittie J, Gottlieb D, Heslop H Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy Blood 1989, 79: 1.351-1.358.
28. Niederwieser D, Gastl G, Rumpold H, Marth CH, Kraft D, Huber CH. Rapid reappearance of large granular lymphocytes (LGL) with concomitant reconstituon of natural killer (NK) activity after human bone marrow transplantation (BMT). Br J Haematol 1987; 65: 301-305.
29. Hofman-Wackersreuther G, Birkmann J, Smetak M, Oez S, Gröschel W, Wand et al. Marker analysis of natural killer cells in the peripheral blood after ABMT/PBSC: coexpression of NK and T cell-associated markers. Burdeos: Proc 20th Annual Meeting of the EMBT, 1994.